Symposium 51: Monoamines in brain function and dysfunction: Insights into epilepsy, addiction, and neurotoxicity
Tracks
Hall III
| Tuesday, June 10, 2025 |
| 15:00 - 16:45 |
| Hall III |
Speaker
Dr. Tatiana Morais
Early Stage Researcher
Icvs
The 5‐HT2C Receptor-Positive Allosteric Modulator CYD-1-79 Does Not Affect Anxiety but Halts Absence Seizures in GAERS
Ms. Chloé Aman
Phd Student
University Of Bordeaux
The Coronaridine Derivatives Catharanthine and 18-MC Exert Anti-Epileptic Activities and Alter Monoaminergic Systems Activity
Prof. Giuseppe Di Giovanni
Magna Græcia University
Modulation of GABAA Receptor Tonic Inhibition and GAT1 Function by 5-HT2A Receptors with a Focus on Absence Epilepsy
Dr. Stephanie Caille-Garnier
Researcher
University Of Bordeaux
Monoamine Functional Connectivity at Rest and Its Link to Inter-Individual Differences in Behavioral Performances
Dr. Gabriele Ruffolo
Assistant Professor
University Of Rome "sapienza"
Targeted over-expression of multiple GABAA receptor subunits increases the sensitivity to GABAergic anti-seizure medications
Organizer
Stephanie Caille-Garnier
Researcher
University Of Bordeaux
Giuseppe Di Giovanni
Magna Græcia University
